臨床検査50巻3号

2006年03月発行

シリーズ最新医学講座・Ⅱ 耐性菌の基礎と臨床・2 主として院内感染で問題となる耐性菌・1

ブドウ球菌(基礎編)

著者： 花木秀明¹²

所属機関： ¹北里研究所 ²抗感染症薬研究センター

ページ範囲：P.327 - P.331

はじめに

　ブドウ球菌は，好気性・通性嫌気性グラム陽性球菌でブドウ房状に生育するため，ブドウ球菌と呼ばれている．本菌は，コアグラーゼ(血漿を固める酵素)を産生する黄色ブドウ球菌(Staphylococcus aureus)と産生しないブドウ球菌(Coagulase-negative Staphylococci；CNS)に分けられる．また，黄色ブドウ球菌はマンニットを資化できるがCNSはできないという特徴もある．臨床で頻繁に検出されるCNSはS. epidermidisやS. heamolyticus，S. saprophyticusなどである．

参考文献

１) Hanaki H, Kuwahara-Arai K, Boyle-Vavra D, et al：Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu 3 and Mu 50. J Antimicrob Chemother　42：199-209, 1998

２) Hanaki H, Labischinski H, Inaba Y, et al：Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant S. aureus (VRSA) strain Mu 50. J Antimicrob Chemother　42：315-320, 1998

３) Cui L, Ma X, Sato K, et al：Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol　41：5-14, 2003

４) Sievert DM, Boulton ML, Stolfman G, et al：Staphylococcus aureus Resistant to Vancomycin…United States, MMWR　51：565-567, 2002

５) Hanaki H, Yamaguchi Y, Nomura S, et al：Method of detecting “β-lactam antibiotic induced vancomycin resistant MRSA (BIVR)”. Int J Antimicrob Agents　23：1-5, 2004

６) 花木秀明：バンコマイシンとβ-ラクタム薬が拮抗するMRSA(BIVR)の疫学調査と臨床への対応．Jpn J Antibiot　57：204-212：2004

７) Lina G, Piemont Y, Godail-Gamot F, et al：Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis　29：1128-1132, 1999

８) Gillet Y, Issartel B, Vanhems P, et al：Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet　359：753-759, 2002

９) Eady EA, Cove JH：Staphylococcal resistance revisited：community-acquired methicillin resistant Staphylococcus aureus―an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis　16：103-124, 2003

10) Vandenesch F, Naimi T, Enright MC, et al：Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes：worldwide emergence. Emerg Infect Dis　9：978-984, 2003

11) Diekema DJ, Pfaller MA, Schmitz FJ, et al：Survey of infections due to Staphylococcus species；frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis　32(Suppl 2)：S114-132, 2001

12) Dufour P, Gillet Y, Bes M, et al：Community-acquired methicillin-resistant Staphylococcus aureus infections in France；emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis　35：819-824, 2002

13) Witte W, Cuny C, Strommenger B, et al：Emergence of a new community acquired MRSA strain in Germany. Euro Surveill　9：16-18, 2004

14) Collignon P, Gosbell I, Vickery A, et al：Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. Lancet　352：145-146, 1998

15) 伊藤輝代，桑原京子，久田研，他：市中感染型MRSAの遺伝子構造と診断(最新の知見)．感染症学会誌　78：459-469, 2004

16) Liu H, Buescher G, Lewis N, et al：Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains. Eur J Clin Microbiol Infect Dis　9：717-724, 1990

17) Suggs AH, Maranan MC, Boyle-Vavra S, et al：Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors. Pediatr Infect Dis J　18：410-414, 1999

18) Longzhu Cui, Jian-Qi Lian, Hui-min Neoh, et al：DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureus. Antimicrob Agents Chemother　49：3404-3413, 2005